The tumor premetastatic niche initiated by primary tumors is constructed by multiple molecular factors and cellular components and provides permissive condition that allows circulating tumor cells to successfully metastasize. Myeloid-derived suppressor cells (MDSCs), a population of immature cells in pathological conditions, play a critical role in the formation of the premetastatic niche. However, few researches are focused on the function of monocytic MDSCs (mo-MDSCs), a subtype of MDSCs, in the construction of the niche. Here, we show that the number of mo-MDSCs is significantly increased in the premetastatic lungs of tumor-bearing mice, thus promoting tumor cell arrest and metastasis. Before the arrival of tumor cells, the lung-recruited mo-MDSCs produced IL-1b, thereby increasing E-selectin expression and promoting tumor cell arrest on endothelial cells. Depletion of mo-MDSCs in the premetastatic lungs decreased IL-1b production, resulting in reduced E-selectin expression. In addition, compared with alveolar macrophages and interstitial macrophages, mo-MDSCs were the major source of IL-1b expression in the premetastatic lungs. Cytokine array analyses and transwell experiments revealed that CCL12 recruits mo-MDSCs to premetastatic lungs. CCL12 knockdown in tumor-bearing mice significantly decreased mo-MDSC infiltration into the premetastatic lungs, leading to reduced E-selectin expression. Overall, the permissive conditions produced by the infiltrated mo-MDSCs correlated with increased tumor cell arrest and metastasis. These results reveal a novel role of mo-MDSCs in constructing the premetastatic niche. Thus, inhibition of mo-MDSCs infiltration may change the premetastatic niche to normal condition and attenuate tumor metastasis.
Tumor metastasis is a complicated process, including tumor cell dissemination from primary foci, infiltration into the vascular system, transit through the circulation, capture in capillary beds, and colonization and formation of metastatic nodules in distant target organs. 1, 2 According to recent studies, tumor metastasis can be separated into three phases: premetastasis, micrometastasis, and macrometastasis. 3 Among them, the construction of premetastatic microenvironment is the most essential step for successful tumor metastasis. Premetastasis is defined as the environment of the distant metastatic target organs, which is rebuilt before the arrival of the tumor cells from the primary foci. This environment is beneficial for tumor cell arrest, survival and proliferation. 4 Construction of the premetastatic microenvironment requires multiple molecular and cellular elements, including primary tumor-secreted growth factors, bone marrow-derived hematopoietic progenitor cells, modified extracellular matrix, disrupted vasculature and the expression of novel signaling molecules and cytokines by stromal cells and endothelial cells. [5] [6] [7] One well-acknowledged concept is that tumor premetastasis occurs in a stepwise fashion. 4 In order to accomplish a distant engraftment, primary tumor cells secrete growth factors, including vascular endothelial growth factor A (VEGFA), transforming growth factor-b (TGF-b), placental growth factor (PlGF) and granulocyte colony stimulating factor (G-CSF). 5, 8 In response to these factors, the expression of inflammatory chemokines and cytokines in lungs is upregulated, thus leading to a recruitment of bone marrow-derived hematopoietic progenitor cells to the premetastatic niche. 9, 10 These newly recruited myeloid cells, together with stromal cells and endothelial cells in the tissue parenchyma, modulate the local microenvironment by secreting chemokines, inflammatory factors and matrix-degrading enzymes, thus providing a platform for tumor cell metastasis. [11] [12] [13] During this process, myeloid-derived suppressor cells (MDSCs), a significant component of the recruited bone marrow-derived hematopoietic cells, play predominant roles in initiating the premetastatic niche and promoting tumor premetastasis. MDSCs are a heterogeneous population of immature cells which are expanded in pathological conditions, such as cancer, acute or chronic infections, and trauma, as well as during the bone marrow transplantation process. 14 These cells consist of myeloid progenitor cells and immature myeloid cells, and characterized by the strong immunosuppressive properties. In mice, the phenotype of MDSCs is commonly defined as CD11b 14 In pathological conditions, the activation of MDSCs results in the upregulation of arginase 1, inducible nitric oxide synthase (iNOS) and reactive oxygen species (ROS), thus leading to the suppression of T-cell responses. 15, 16 Beyond their immunosuppressive functions, studies have also reported that MDSCs are recruited in the premetastatic niche and metastatic niche and have significant roles in promoting tumor metastasis. 17 In response to tumor-secreted factors, such as VEGFA, GM-CSF and G-CSF, MDSCs may further differentiate and participate in promoting tumor neovascularization. 18, 19 MDSCs consist of two subtypes: granulocytic MDSCs (GMDSCs) and monocytic MDSCs (mo-MDSCs). In mice, GMDSCs have a CD11b In this study, we report that mo-MDSCs are recruited into the lungs of mice with melanoma before the arrival of tumor cells, and the recruited mo-MDSCs promote E-selectin expression in the endothelial cells by secreting IL-1b, thus leading to increased distant metastasis. Our results reveal that the recruited mo-MDSCs have important roles in rebuilding the microenvironment of premetastatic lungs.
Material and Methods
Mice and cell lines C57BL/6 mice were purchased from the Animal Experimental Center of Jilin University (Changchun, China). Mice were housed in a pathogen-free environment, and all animal procedures performed were approved by the Animal Care Committee of the Northeast Normal University, China. Experimental animals were used at 8 to 10 weeks of age. B16F10 cells and HEK-293T cells were purchased from the American Type Culture Collection (ATCC). The MS1 cells were a gift from Dr. Zheng (Institute of Genetics and Cytology, Northeast Normal University). All cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (HyClone) and 1% penicillin/streptomycin (Sigma).
Reagents and antibodies
The reagents and antibodies are listed in the Supporting Information for Material and Methods.
Single cell preparation and flow cytometry analysis
Flow cytometry was performed by using a FACSCantoII (BD Biosciences), and data were analyzed with FACSDiva software (BD Biosciences) and Flow Jo 7.6.1 software. Detailed information was described in the Supporting Information for Material and Methods.
What's new? During premetastasis, the tissue microenvironment of distant metastatic target organs is altered to permit habitation for circulating tumor cells. Premetastatic niche formation is influenced by granulocytic myeloid-derived suppressor cells (G-MDSCs), but according to this study, the other major MDSC subtype, monocytic MDSCs (mo-MDSCs), hitherto unknown factors in premetastatic niche construction, are also critical. In tumor-bearing mice, mo-MDSCs were greatly increased in premetastatic lung tissue, where they produced IL-1b, thereby promoting E-selectin expression and subsequent tumor cell adhesion to the vascular endothelium. Lung infiltration by mo-MDSCs was significantly decreased via knockdown of chemokine (C-C motif) ligand 12 (CCL12).
Tumor cell arrest and metastasis assay B16F10 cells were first stained with PKH26, according to the manufacturer's instructions, and then 2 3 10 5 PKH26-stained B16F10 cells were i.v. injected into the untreated normal mice, tumor-bearing mice and mo-MDSCs adoptive transferred tumor-bearing mice. The lungs of the treated mice were collected and perfused with PBS to remove the circulating tumor cells in the blood vessels 3 h after the tumor cells were injected. Frozen sections were generated, and the PKH26-B16F10 cells were detected under a fluorescence microscope (Nikon Eclipse 80i). To detect metastasis, 2 3 10 5 B16F10 cells were i.v. injected, and the mice were sacrificed to analyze the number of metastatic foci 2 weeks after the tumor cells were injected.
Cell isolation
mo-MDSCs and G-MDSCs were sorted with a MyeloidDerived Suppressor Cell Isolation Kit using AutoMACS sorter (Miltenyi Biotec) according to the manufacturer's instructions. Detailed information was described in the Supporting Information for Material and Methods.
MDSCs depletion and mo-MDSCs replenishment in vivo
MDSC depletion was carried out as described by Vincent et al. 
RT-PCR and real-time PCR analysis
Experiments were carried out as described in the Supporting Information for Material and Methods.
Fluorescence IHC staining and hematoxylin and eosin (H&E) staining
Construction of the lentiviral expression plasmid and transfection
A detailed description of procedures is presented in the Supporting Information for Material and Methods.
Co-culture system MS1 cells were plated in 6 cm plates at a density of 10 6 cells/ plate on the first day. On the second day, the mo-MDSCs and G-MDSCs were isolated from the blood of tumorbearing mice, and the alveolar macrophages were harvested from the alveolar lavage fluid. Then the collected cells were added to the plates in the presence or absence of TCM (tumor-conditioned medium). Two hours later, the supernatants were discarded, and the MS1 cells were collected for western blot analysis. In a separate experiment, the coculture system was administrated with IL-1Ra at a concentration of 25 lg/mL.
Static adhesion assay
Cytokine array for lung tissue
For the cytokine array, the lung tissues were lysed with lysis buffer and processed according to the manufacturer's instructions (R&D Systems).
In vitro migration assay
The migration of mo-MDSCs was evaluated using a transwell chamber with 5 lm pores (Corning). Blood was collected, and the erythrocytes were eliminated using hypotonic lysis buffer. The remaining cells were separated into two layers using Ficoll (Sigma-Aldrich). The cells in the middle layer (5 3 10 4 cells) were seeded in the upper wells, and chemokines, such as CCL12, CCL2, CXCL10 or IL-1b, were placed in the lower wells. The plates were incubated at 378C for 3 h with 5% CO 2 . The cells that had migrated to the lower wells were collected and stained with antibodies to examine the absolute number of transmigrated mo-MDSCs using flow cytometry.
Statistical analysis
The data were analyzed using Student's t-test and presented as the means 6 SEM. Significance was determined as p < 0.05.
Results

Mo-MDSCs are recruited to the premetastatic niche in tumor-bearing mice
It has been reported that the number of circulating MDSCs is increased in the tumor-bearing mice, 27 and the G-MDSC subset is recruited into the premetastatic niche. 25 To examine whether the mo-MDSCs is recruited in the premetastatic niche, a tumor premetastatic model was established by subcutaneously inoculating 3 3 10 6 B16F10-GFP cells into the flanks of C57BL/6 mice. The B16F10 cells have been reported to specifically metastasize to the lungs. 28 Then, we explored the time course over which the metastatic B16F10 cells arrived at the lungs. No band was found until the 5th week from our RT-PCR results, indicating that the tumor cells did not arrive at the lungs until 5 weeks after subcutaneous inoculation (Fig. 1a a) . This result was confirmed by the histological staining, which showed that the B16F10-GFP cells began to metastasize to the lungs in the 5th week (Fig. 1a b) . Then, we examined the expression of cytokines in lungs, which have been reported to be hallmarks of premetastatic niche formation. 4, 29 As shown in Figure 1b ; a, a significant increase in S100A8, S100A9 and IL-1b was observed in the lungs from the 2nd week to the 4th week ( Fig. 1b; a) . IFN-g expression in CD8
1 T cells in the lungs, which was the indicative of immune response, was significantly decreased from the 2nd week ( Fig. 1b ; b, Supporting Information 1). Both of these results indicate that the inflammatory and immunosuppressive premetastatic niche begin to form from the 2nd week. Therefore, the period of premetastatic niche formation is defined as from the 2nd week to the 4th week in the present study.
The premetastatic niche is a reconstructed environment that is ready for tumor cells to metastasize. Therefore, we next examined the structural alterations in the premetastatic lungs. A clear increase in the cellular density and a reduction in the alveolar space were observed in the lungs of the tumor-bearing mice compared with the untreated normal mice, as observed by H&E staining and counting the exact number of cells per field (Fig. 1c) . These changes indicated that during the formation of premetastatic niche, a large number of cells were recruited to the lungs. To investigate whether the increased number of cells includes mo-MDSCs, the proportion of mo-MDSCs out of CD45-positive cells was examined in the lungs of tumor-bearing mice at different time points. A significant increase in the percentage of moMDSCs was observed compared with normal mice, and the increase started at the 2nd week and reached the maximum in the 3rd week. The proportion of G-MDSCs was also examined, and the results showed that the percentage continued to increase from the 2nd week (Figs. 1d and 1e) . Although the proportion of mo-MDSCs decreased in the 4th week, the absolute number of the cells did not decrease (Supporting Information 2). Together, these data suggest that moMDSCs and G-MDSCs are recruited to the lungs before the arrival of tumor cells. Furthermore, there was no detectable increase in the numbers of mo-MDSCs and G-MDSCs in the hearts, kidneys and livers of the tumor-bearing mice compared with the normal mice (Supporting Information 3), thus further confirming that the lung is a tropism of B16F10 cells that have a priority to metastasize. 25 
mo-MDSC-promoted tumor cell arrest is associated with an increase of E-selectin expression
Because an increased number of mo-MDSCs were observed in the premetastatic lungs, we hypothesized that the recruited mo-MDSCs may be associated with premetastatic niche construction and tumor cell metastasis. To precisely monitor the arrest and outgrowth of tumor cells following the entry of tumor cells into the bloodstream, we used an experimental lung metastasis model by intravenously injecting B16F10 cells to mice. Results showed that a significant increased number of metastatic foci were detected in the tumor-bearing mice compared with the normal mice 2 weeks after injection (Fig.  2a) . To test if the recruited mo-MDSCs are responsible for the increased tumor metastasis, we isolated the mo-MDSCs from blood of the tumor-bearing mice, and examined their purity by FSC (90%). The isolated mo-MDSCs were intravenously injected into the subcutaneous tumor-bearing mice, and an increased number of mo-MDSCs was detected in the premetastatic lungs 24 h later (Supporting Information 4). In parallel experiments, 24 h after mo-MDSCs transplantation, the mice were intravenously injected with B16F10 cells. The number of metastatic foci was evaluated in lungs of the treated mice. A significant increase of metastatic foci was observed in the mo-MDSCs-transferred tumor-bearing mice compared with the untreated tumor-bearing mice (Fig. 2a) . Because successful distant metastasis requires the arrest of surviving tumor cells in blood vessels, 30 we also counted the number of arrested tumor cells in the lungs 3 h after the mice were intravenously injected with PKH26-stained B16F10 cells. A dramatic increase of tumor cell arrest was observed in the lungs of the mo-MDSCs-transferred tumorbearing mice compared with the tumor-bearing mice and untreated normal mice (Fig. 2b) . Together, these results indicate that the recruited mo-MDSCs in the premetastatic niche promote tumor cell arrest and metastasis.
The arrest of tumor cells requires an interaction between adhesion molecules on the tumor cells and receptors on the vascular endothelium. 31 The known adhesion receptors on endothelial cells that play functions in the adhesion of tumor cells are E-selectin and P-selectin. 32, 33 Therefore, the Eselectin and P-selectin expression levels in the lungs of the subcutaneous tumor-bearing mice and untreated normal mice were determined. The protein was extracted from the whole lungs, and results showed that E-selectin expression was dramatically increased in the premetastatic niche from the 2nd week and reached a maximum in the 3rd week ( Fig.  2c; a) . This result was further confirmed by immunohistochemistry ( Fig. 2c; b) . P-selectin expression was also examined, but no significant change was detected (data not shown). Furthermore, the expressions of ICAM-1, VCAM-1 and PECAM-1, which participate in the later stage of extravasation cascade of tumor cells, were examined, and data showed that the expression of PECAM-1 was increased during the premetastatic phase, while ICAM-1 and VCAM-1 did not change (Supporting Information 5). To test the function of E-selectin in the premetastatic lungs, lentivirus-based RNA interference against E-selectin was intrapleurally injected into 2-week tumor-bearing mice three times in 1 week according to a previous report. 34 Then mice were intravenously injected with PKH26-stained B16F10 cells. Data showed that when Eselectin expression was effectively knocked down in the lungs of tumor-bearing mice ( Fig. 2d; a) , the number of arrested tumor cells was significantly decreased compared with shCtrl tumor-bearing mice ( Fig. 2d; b) . Furthermore, no significant change in E-selectin expression was detected in the hearts, kidneys and livers of the tumor-bearing mice compared with the normal mice (Supporting Information 6). Together, these data suggest that E-selectin expression is upregulated in the premetastatic niche, which is responsible for tumor cell arrest.
The recruitment of mo-MDSCs promotes E-selectin expression in the premetastatic lungs
Because the recruited mo-MDSCs promoted tumor arrest (Fig. 2b ) and E-selectin expression was increased in the premetastatic lungs (Fig. 2c) , we tested whether the recruited mo-MDSCs in the lung contribute to E-selectin expression. The isolated mo-MDSCs were intravenously injected into 2- week tumor-bearing mice, and the lung proteins were extracted 24 h after injection. Results showed that the transfer of mo-MDSCs to tumor-bearing mice increased the expression of E-selectin in premetastatic lungs (Fig. 3a) , indicating that the mo-MDSCs contribute to E-selectin expression.
A depletion assay was conducted to further confirm the function of mo-MDSCs in promoting E-selectin expression in premetastatic lungs. Anti-Gr1 antibody (RB6-8C5) was widely used as it was considered to be effective in eliminating MDSC. 26 As shown in Figure 3b , the number of lungrecruited mo-MDSCs was significantly increased in tumorbearing mice compared with normal mice ( Fig. 3b; a, e) . The depletion of MDSCs in tumor-bearing mice with a Gr1-specific antibody markedly decreased the numbers of both GMDSCs and mo-MDSCs in the lung of tumor-bearing mice, reducing the percentage of mo-MDSCs from about 8% to 5%, which approximate the level of mo-MDSCs in untreated normal mice (about 4.5%) ( Fig. 3b; b) . After depleting both MDSCs, the G-MDSCs were replenished to simulate the mo-MDSC depletion ( Fig. 3b ; c, c'). As expected, the depletion of both MDSCs decreased E-selectin expression to a normal level. When only the mo-MDSCs were depleted, there was a substantial reduction in E-selectin expression in the tumorbearing mice (Fig. 3c) . Upon depletion of the G-MDSCs alone ( Fig. 3b; d, d' ), E-selectin expression was also reduced compared with tumor-bearing mice, but to a lesser extent (Fig. 3c) . Together, our data suggest that the recruited moMDSCs play an essential role in promoting E-selectin expression in the premetastatic niche.
To further examine the contributions of mo-MDSCs and G-MDSCs to E-selectin expression, we performed ex vivo cocultures of MS1 cells (an endothelial cell line) with moMDSCs or G-MDSCs, which were isolated from the blood of tumor-bearing mice. The co-culture of mo-MDSCs with MS1 directly promoted E-selectin expression in the MS1 cells incubated in either tumor-free or tumor-conditioned medium, and no significant changes were detected in the coculture with G-MDSCs (Fig. 3d ). E-selectin is a cell adhesion molecule which is expressed only in endothelial cells activated by cytokines, 35 and result showed that there was no Eselectin expression in mo-MDSCs (data not shown). These data further verified that the isolated mo-MDSCs promoted E-selectin expression in endothelial cells.
To gain more insight into the association between moMDSCs and E-selectin expression, the primary tumor was surgically resected, since the expansion of mo-MDSCs is induced by the primary tumor. 27 We found that the number of mo-MDSCs in the lungs was still high 1 week after surgery and significantly decreased 2 weeks later (Fig. 3e, upper) . Eselectin expression was also decreased 2 weeks after surgery, compared with that in tumor-bearing mice (Fig. 3e, lower) . These data suggest that E-selectin expression is closely associated with the recruited mo-MDSCs in premetastatic lungs.
E-selectin expression in endothelial cells is induced by mo-MDSC-secreted IL-1b in premetastatic lung
During inflammation, the activated macrophages induce Eselectin expression by secreting TNF-a and IL-1b, which were reported to be the only factors stimulating E-selectin expression (Supporting Information 7) . 36 In the present study, we showed that the recruited mo-MDSCs in the premetastatic lungs contributed to E-selectin expression, but the molecules mediating this process remain to be elucidated. Real-time PCR was performed to determine the differences in TNF-a and IL-1b expression in the lungs of normal mice and tumor-bearing mice. The data showed that IL-1b expression was greatly upregulated in the tumor-bearing mice, while TNF-a expression was not changed (Fig. 4a) . When both MDSCs were depleted in the tumor-bearing mice, IL-1b expression was decreased to the level in the control lung, and the same level was detected after the mo-MDSCs were depleted in the tumor-bearing mice. However, when only the G-MDSCs were depleted, IL-1b expression was also reduced but not to the level of control mice (Fig. 4a) . Therefore, IL1b, rather than TNF-a, was identified as the mediator of Eselectin expression in premetastatic lungs. The above results were further confirmed by western blot analysis (Fig. 4b ). Then, we tested the interaction between the tumor cells and MS1 cells through static adhesion assays, which could mimic tumor adhesion in vivo. The number of adherent tumor cells increased when the MS1 cells were stimulated with IL-1b, which was accompanied with an increase in E-selectin expression in the MS1 cells (Fig. 4c) . When E-selectin was effectively knocked down in MS1 cells, the number of adherent tumor cells was also decreased (Fig. 4c) . Together, these data suggest that the mo-MDSCs are closely associated with IL-1b expression and IL-1b promotes E-selectin expression in endothelial cells.
To assess whether the increased IL-1b in the premetastatic lung is produced by the recruited mo-MDSCs, we examined IL-1b expression at the single-cell level in the lungs by flow cytometry. 37 The data showed that there was more IL-1b expression in the immune cells of tumor-bearing mice (Fig.  4d) , and the number of IL-1b-expressing mo-MDSCs in the lungs of tumor-bearing mice was much higher than that in normal mice (Fig. 4e) . As indicated above, the co-culture of isolated mo-MDSCs with MS1 cells stimulated E-selectin expression; therefore, we analyzed whether this process was mediated by IL-1b. As shown by the results of real-time PCR and flow cytometry, compared with the mo-MDSCs that were freshly isolated from blood of tumor-bearing mice, the cultured mo-MDSCs presented higher IL-1b expression in vitro ( Fig. 1f; a, b) . Furthermore, our results showed that the expression of E-selectin was significantly decreased when IL1Ra was administrated to the ex vivo co-culture system or the tumor-bearing mice (Fig. 4g a, b) , strengthening the proposed role of IL-1b. Together, these data indicate that the lung-recruited mo-MDSCs produce IL-1b, which then contributes to E-selectin expression on endothelial cells. mo-MDSCs are the major contributor of IL-1b expression in the lungs of tumor-bearing mice IL-1b is mainly secreted by activated macrophages during inflammation. 35 In lung, macrophages are divided into two populations, alveolar macrophages (CD11c
and interstitial macrophages (CD11c 1 F4/80 1 CD11b 1 ) (Fig.   5a ). 38 Then, the numbers of both types of macrophages were examined. The data showed that the absolute numbers of alveolar macrophages and interstitial macrophages were increased from the 3rd week (Fig. 5b) , although their proportions were both decreased during the premetastatic phase (Fig. 5c ). These changes suggest that both subtypes of macrophages are likely to contribute to the construction of the premetastatic niche. Then, we examined IL-1b expression in both subtypes of macrophages in the lungs of tumor-bearing mice, and compared it with mo-MDSCs. The results showed that the alveolar macrophages did not express IL-1b, but the mo-MDSCs and interstitial macrophages were positive for IL-1b expression (Fig. 5d) , suggesting that the interstitial macrophages might also contribute to IL-1b expression. Then, we counted the number of macrophages and mo-MDSCs, and data showed that mo-MDSCs were the predominant population in the premetastatic lungs (Fig. 5e) , indicating that mo-MDSCs, but not interstitial macrophages, were the major source of IL-1b production.
Because alveolar macrophages have been reported to contribute to the premetastatic niche, 38 we further isolated alveolar macrophages and co-cultured them with MS1 cells. Notably, no significant elevation of E-selectin expression was detected when the MS1 cells were co-cultured with alveolar macrophages (M/) compared with the co-culture of MS1 with mo-MDSCs (Fig. 1f) , implying that the way that alveolar macrophages promote premetastasis reported before is not by increasing E-selectin expression. Together, these results demonstrate that mo-MDSCs, not interstitial macrophages and alveolar macrophages, are responsible for most of the IL-1b production in the lungs of tumor-bearing mice.
CCL12 is a major cytokine that recruits mo-MDSCs to the premetastatic niche
To determine the cytokines that recruit mo-MDSCs to the premetastatic niche, we performed a mouse cytokine array using tissue lysates from normal lungs and premetastatic lungs. The results showed that the expression of cytokines, such as IL-1b, CXCL10, CCL12 and CCL2, was increased in the premetastatic lungs (Fig. 6a) . Based on the results above, a cell migration assay was performed using a transwell chamber to examine the chemotaxis of IL-1b, CXCL10, CCL2 and CCL12 for mo-MDSCs. The results showed that both CCL2 and CCL12 displayed a dose-dependent increase in their ability to recruit mo-MDSCs, and the ability of CCL12 in recruiting mo-MDSCs was greater than CCL2, whereas IL-1b and CXCL10 did not appear to recruit mo-MDSCs (Fig. 6b,  Supporting Information 8) . Together, these data indicate that the increased CCL12 expression in the premetastatic niche might be responsible for the recruitment of mo-MDSCs. Then, we examined the chemotaxis of CCL12 in vivo. Results showed that the intranasal administration of CCL12 to 2-week tumor-bearing mice markedly increased the recruitment of mo-MDSCs to the lungs (Fig. 6c) . In parallel, E-selectin expression was also upregulated compared with the 2-week tumor-bearing mice and normal mice which were treated with PBS ( Fig. 6d; a) . To exclude the possibility that the increased E-selectin expression was directly induced by CCL12, MS1 cells were cultured with CCL12 alone. The data showed that there was no increase in E-selectin expression. When the MS1 cells were co-cultured with mo-MDSCs or both mo-MDSCs and CCL12, E-selectin expression was increased ( Fig. 6d; b) , suggesting that CCL12 administration only increased mo-MDSCs recruitment but did not directly induce E-selectin expression in endothelial cells.
To further investigate the function of CCL12 on mo-MDSC recruitment in the premetastatic lungs, lentivirusbased RNA interference against CCL12 was performed through intrapleural lentivirus injections. In the premetastatic lungs, mo-MDSC recruitment and E-selectin expression was significantly decreased when CCL12 was silenced (Fig. 6e) . These data indicate that CCL12 deficiency decreased mo-MDSC recruitment and E-selectin expression. Together, these data suggest that CCL12 is a major chemokine in recruiting mo-MDSCs to the premetastatic niche.
Discussion
It is widely accepted that the formation of the premetastatic niche in distant organs promotes tumor metastasis. A variety of cytokines and bone marrow-derived cells orchestrate premetastatic niche formation. MDSCs, a significant type of bone marrow-derived cells, may shift from exerting immune responses to immunosuppressive responses, and they have been implicated in the construction of premetastatic niche. 5 In the present work, we showed that mo-MDSCs, a subset of MDSCs, are recruited to the premetastatic niche, and the lung-recruited mo-MDSCs induce E-selectin expression in endothelial cells by producing IL-1b. Moreover, E-selectin expression is responsible for the arrest and metastasis of tumor cells. In addition, CCL12 expression in the premetastatic niche participates in the mo-MDSC recruitment.
The infiltration of MDSCs in the premetastatic niche promotes tumor immune evasion 39 and vascular remodeling, 8 ultimately causing a conversion from immune protection to tumor promotion. 23 Therefore, the direct correlation between tumor progression and the immune suppression of MDSCs has generally been accepted. 17 In our experimental model, the numbers of both G-MDSCs and mo-MDSCs were increased in the premetastatic lungs, and the increase in the number of mo-MDSCs preceded the arrival of tumor cells, implicating their significant role in preparing the metastatic "soil." Previous studies have shown that MDSCs, along with their associated stromal cells, reform the premetastatic niche by producing MMP9, versican and LOX. 4 The G-MDSCs subset is involved in angiogenesis through enhancing the bioactivity of VEGF, Bv8 or possibly other angiogenic factors, 9, 40 and regulation of tumor invasion through MMPs or TGFb. 41, 42 Although multiple studies have focused on the functions of MDSCs and G-MDSCs in the construction of premetastatic niche, the role of mo-MDSCs in this process remains unclear. We found that the mo-MDSCs were recruited to the premetastatic lungs, and an i.v. injection of isolated moMDSCs into tumor-bearing mice significantly increased tumor cell arrest and metastasis. Because tumor cell arrest and metastasis are closely correlated with the formation of premetastatic niche, it is believed that lung-recruited moMDSCs participate in the construction of premetastatic niche. Therefore, in this study, we reported a novel role of moMDSCs in promoting tumor metastasis.
The construction of premetastatic niche requires multiple factors, including diverse molecular and cellular elements. 4 In the metastatic phase, the initial adhesion of tumor cells on a blood vessel plays an essential role for successful metastasis. 31 Previous work has documented that a selectin deficiency decreases the number of disseminated tumor cells. 43 Furthermore, E-selectin and P-selectin, the adhesion molecules involved in inflammation and tumor metastasis, mediate the initial adhesion of immune cells and tumor cells, 32, 33, 43 and E-selectin expression directs the distribution of tumor cells in the metastatic stage. 3, 44 We showed that E-selectin expression increased during the premetastatic phase and was associated with tumor arrest, suggesting that the increased E-selectin expression was needed to capture the circulating tumor cells. Previous studies have reported that tumor-secreted factors, such as VEGF and PlGF, upregulate E-selectin expression in the metastatic foci. 45 Therefore, as long as the distant organs are exposed to these tumor-secreted factors, E-selectin expression might be increased. However, our results showed that although all organs are equally exposed to the tumorsecreted factors, the increased E-selectin expression was detected only in the lung, the organ to which the B16F10 cells subsequently metastasized. Notably, we observed that the increased E-selectin expression was the result of mo-MDSC recruitment in the premetastatic lungs, and depletion of mo-MDSCs attenuated E-selectin expression. In addition, exposure endothelial cells to tumor-conditioned medium did not directly induce E-selectin expression, excluding the possibility that the increased E-selectin expression was mediated by tumor-secreted factors. Furthermore, we discovered that mo-MDSC recruitment was also organ-specific, which was consistent with the E-selectin expression, further confirming that mo-MDSCs promote E-selectin expression.
Inflammatory responses play a critical role at different stages of tumor progression. 46, 47 Previous studies have reported that both TNF-a and IL-1b participate in tumor progression by contributing to tumor cell growth and movement. 48, 49 In the present work, we showed that IL-1b expression, rather than TNF-a expression, was increased in the lungs of tumor-bearing mice. Furthermore, we found that the expression of IL-1b was decreased when the mo-MDSC were depleted in vivo. The comparison of the IL-1b expression level in macrophages and mo-MDSCs further showed that moMDSCs were the major source of IL-1b production. Although the ability of MDSCs to produce IL-1b under inflammatory conditions has been documented, 50 our work provides the first demonstration that the lung-recruited moMDSCs secrete IL-1b, which in turn promotes E-selectin expression in tumor-bearing mice.
In summary, our present study reported a new role of the lung-recruited mo-MDSCs in the construction of premetastatic niche. Based on these data, we propose the following model. In response to the primary tumor, CCL12 expression is upregulated in the premetastatic lung, which results in mo-MDSC recruitment. The recruited mo-MDSCs secrete IL-1b, which in turn stimulates the expression of E-selectin in endothelial cells. E-selectin expression in endothelial cells increases the arrest and metastasis of circulating tumor cells (Supporting Information 9). Therefore, our findings may provide insights into the control or elimination of the arrest and metastasis of tumor cells by blocking mo-MDSC recruitment or CCL12 expression.
